Sol-Gel Technologies (SLGL) Revenue Growth (5y) (2023 - 2026)
Sol-Gel Technologies (SLGL) Revenue Growth (5y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,094.26 Bn | 68,093.97 Bn | - |
| 2 | Nanobiotix | 1,939.09 Bn | 1,939.02 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.34 Bn | 116.09 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.13 Bn | 61.38 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.96 Bn | 62.96 Bn | - |
| 8 | Argenx Se | 56.38 Bn | 51.20 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.67 Bn | 34.66 Bn | 959.66 Mn |
| 10 | Sol-Gel Technologies | 243.93 Mn | 233.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -31.21% |
| Dec 31, 2025 | -19.49% |
| Sep 30, 2025 | -28.33% |
| Jun 30, 2025 | 72.41% |
| Mar 31, 2025 | -21.53% |
| Dec 31, 2024 | -41.39% |
| Sep 30, 2024 | 2.52% |
| Jun 30, 2024 | -6.96% |
| Dec 31, 2023 | 195.55% |
| Sep 30, 2023 | 41.16% |
| Jun 30, 2023 | 64.71% |